Abstract
Research related to the etiology and mechanisms of immunodeficiency in B-cell neoplasms has helped to identify prophylactic and therapeutic measures to manage infections, which remain the leading cause of death despite antimicrobial therapy. In both CLL and multiple myeloma, defective antibody formation is a key risk factor for developing infection. Preliminary data indicate that IVIG replacement therapy is an effective and safe means to improve the antibody profile and reduce the incidence of infection in some patients with either of these B-cell malignancies. Replacement therapy alone is not sufficient. However, in a subset of affected patients who experience recurrent infections, IVIGs may be beneficial as adjunctive therapy when used in conjunction with chemotherapy for the underlying malignancy and antibiotic therapy for acute infections. Further studies are needed to better define their role and to identify those patients who are most likely to benefit from IVIGs.
Similar content being viewed by others
References
Cooper, M. D. (1987),N. Engl. J. Med. 17, 1452–1456.
Fu, S. M., Winchester, R. J., and Kunkel, H. G. (1975),J. Immunol. 114, 250–252.
Salsano, F., Frøland, S. S., Natvig, J. B., and Michaelsen, T. E. (1974),Scand. J. Immunol. 3, 841–846.
Ternynck, T., Dighiero, G., Folleqou, J., and Binet, J.-L.(1974),Blood 43, 789–795.
Gale, R. P. and Foon, K. A. (1987),Sem. Hematol. 24, 209–229.
Gale, R. P. and Foon, K. A. (1985),Ann. Intern. Med. 103, 101–120.
Caligaris-Cappio, F. and Janossy, G. (1985),Sem. Hematol. 22, 1–12.
Freedman, A. S. and Nadler L. M. (1987),Sem. Hematol. 24, 230–239.
Anderson, K. C., Bates, M. P., Slaughenhoupt, B. L., Pinkus, G. S., Schlossman, S. F., and Nadler, L. M. (1984),Blood 63, 1424–1433.
Boumsell, L., Coppin, H., Pham, D., Raynal, B., Lemerle, J., Dausset, J., and Bernard, A. (1980),J. Exp. Med. 152, 229–234.
Caligaris-Cappio, F., Gobbi, M., Bofill., M., and Janossy, G. (1982),J. Exp. Med. 155, 623–628.
Gadol, N. and Ault, K. A. (1986),Immunol. Rev. 93, 23–34.
Hayakawa, K., Hardy, R. R., Parks, D. R., and Herzenberg, L. A. (1983),J. Exp.Med. 157, 202–218.
Herzenberg, L. A., Stall, A. M., Lalor, P. A., Sidman, C., Moore, W. A., Parks, D. R., and Herzenberg, L. A. (1986),Immunol. Rev. 93, 81–102.
Antin, J. H., Emerson, S. G., Martin, P., Gadol, N., and Ault, K. A. (1986),J. Immunol. 136, 505–510.
Ault, K. A., Antin, J. H., Ginsburg, D., Orkin, S. H., Rappeport, J. M., Keohan, M. L., Martin, P., and Smith, B. R. (1985),J. Exp. Med. 161, 1483–1502.
Whelan, C. A., Willoughby, R., and McCann, S. R. (1983),Acta Haematol. 69, 217–223.
Slungaard, A. and Smith, M. J. (1974),Scand. J. Haematol. 12, 112–116.
Whiteside, T. L., Winkelstein, A., and Rabin, B. S. (1977),Cancer 39, 1109–1118.
Montserrat, E., Marques-Pereira, J. P., Gallart, M. T., and Rozman, C. (1984),Cancer 54, 447–451.
Chapel, H. M. and Bunch, C. (1987),Sem. Hematol. 24, 291–296.
Fairley, G. H. and Scott, R. B. (1961),Br. Med. J. 4, 920–924.
Ben-Bassat, I., Many, A., Modan, M., Peretz, C., and Ramot, B. (1979),Am. J. Med. Sci. 278, 4–9.
Arnold, C. and McPhedran, P. (1985),Blood 66, 170A.
Rozman, C., Montserrat, E., and Vinolas, N. (1988),Cancer 61, 279–283.
Foa, R., Catovsky, D., Brozovic, M., Marsh, G., Ooyirilangkumaran, T., Cherchi, M., and Galton, D. A. G. (1979),Cancer 44, 483–487.
Cone, L. and Uhr, J. W. (1964),J. Clin. Invest. 43, 2241–2248.
Qian, G.-X., Fu, S. M., Solanki, D. L., and Rai, K. R. (1984),J. Immunol. 133, 3396–3400.
Hamblin, T. J., Oscier, D. G., and Young, B. J. (1986),J. Clin. Pathol. 39, 713–716.
Catovsky, D., Miliani, E., Okos, A., and Galton, D. A. (1974),Lancet 2, 751–752.
Kay, N. E., Oken, M. M., and Perri, R. T. (1983),J. Clin. Oncol. 1, 810–816.
Keller, R. H., Blake, D. G., Lyman, S., and Siebenlist, R. (1981),J. Clin. Lab. Immunol. 6, 201–209.
Perri, R. T. and Kay, N. E. (1986),Am. J. Hematol. 22, 55–61.
Foa, R., Fierro, M. T., Lusso, P., Raspadori, D., Ferrando, M. L., Matera, L., Malavasi, F., and Lauria, F. (1986),Br. J. Haematol. 62, 151–154.
Platsoucas, C. D., Fernandes, G., Gupta, S. L., Kempin, S., Clarkson, B., Good, R. A., and Gupta, S. (1980),J. Immunol. 125, 1216–1223.
Ziegler, H.-W., Kay, N. E., and Zarling, J. M. (1981),Int. J. Cancer 27, 321–327.
Potter, M. (1971),N. Engl. J. Med. 284, 831–838.
Birgens, H. S., Espersen, F., Hertz, J. P., Pedersen, F. K., and Drivsholm, A. (1983),Scand. J. Haematol. 30, 324–330.
Pruzanski, W., Gidon, M. S., and Roy, A. (1980),Clin. Immunol Immunopathol. 17, 280–286.
Theml, H. and Ziegler-Heitbrock, H. W. L. (1984),Cancer Res. 93, 240–258.
Chapel, H. M. (Gale, R. P. and Rai, K. R., eds.),Chronic Lymphocytic Leukemia: Recent Progress and Future Direction. Alan R. Liss, New York (1987). pp. 383–389.
Kunicka, J. E. and Platsoucas, C. D. (1986),Leukemia Res. 10, 1101–1107.
Moore, J. S., Prystowsky, M. B., Hoover, R. G., Besa, E. C., and Nowell, P. C. (1988),Blood 71, 1012–1020.
Han, T., Ozer, H., Henderson, E. S., Dady, B., Nussbaum-Blumenson, A., and Barcos, M. (1981),Blood 58, 1182–1189.
Arai, S., Yamamoto, H., Itoh, K., and Kumagai, K. (1983),J. Immunol. 131, 651D657.
Clement, L. T., Grossi, C. G., and Gartland, G. L. (1984),J. Immunol. 133, 2461–2468.
Mangan, K. F., Hartnett, M. E., Matis, S. A., Winkelstein, A., and Abo, T. (1984),Blood 63, 260–269.
Hansson, M., Beran, M., Andersson, B., and Kiessling, R. (1982),J. Immunol. 129, 126–132.
Holmberg, L. A., Miller, B. A., and Ault, K. A. (1984),J. Immunol. 133, 2933–2939.
Kay, N. E. and Perri, R. T. (1989),Blood 73, 1016–1019.
Kunicka, J. and Platsoucas, C. D. (1988),Scand. J. Immunol. 28, 1–10.
Dighiero, G. (1987),Sem. Hematol. 24, 240–251.
Broder, S., Humphrey, R., Durm, M., Blackman, M., Meade, B., Goldman, C., Strober, W., and Waldmann, T. (1975),N. Engl. J. Med. 293, 887–892.
Ullrich, S. and Zolla-Pazner, S. (1982),Clin. Hematol. 11, 87–111.
Jacobson, D. R. and Zolla-Pazner, S. (1986),Semin. Oncol. 13, 282–290.
Berman, J. E. and Zolla-Pazner, S. (1985),J. Immunol. 134, 2872–2878.
Dillman, R. O., Royston, I., Meserve, B. L., and Griffiths, J. C. (1981),Cancer 48, 2211–2217.
Pilarski, L. M., Mant, M. J., Ruether, B. A., and Beich, K. A. (1984),J. Clin. Invest. 74, 1301–1306.
Pilarski, L. M., Andrews, D. J., Mant, M. J., and Ruether, B. A. (1986),J. Clin. Immunol. 6, 491–501.
Pilarski, L. M., Mant, M. J., and Ruether, B. (1985),Blood 66, 416–422.
Paglieroni, T. and MacKenzie, M. R. (1977),J. Clin. Invest. 59, 1120–1133.
Ozer, H., Han, T., Henderson, E. S., Nussbaum, A., and Sheedy, D. (1981),J. Clin. Invest. 67, 779–789.
Perri, R. T., Oken, M. M., and Kay, N. E. (1982),J. Lab. Clin. Med. 99, 512–519.
Pezzutto, A., Semenzato, G., Agostini, C., Raimondi, R., and Gasparotto, G. (1981),Scand. J. Haematol. 28, 333–338.
Bergmann, L., Mitrou, P. S., Weber, K. C., and Kelker, W. (1984),Clin. Immunol. Immunother. 17, 112–116.
Serra, H. M., Mant, M. J., Ruether, B. A., Ledbetter, J. A, and Pilarski, L. M. (1988),J. Clin. Immunol. 8, 259–265.
Theml, H., Bergmann, H., and Rastetter, J. (1982), Therapie Bsartiger Blutkrankheiten (Scheurten, P. G. and Pees, H. W., eds.), Springer-Verlag, Berlin.
Shaw, R. K., Szwed, C., Boggs, D. R., Fahey, J. L., Frei, E., Morrison, E., and Utz, J. P. (1960),Arch. Intern. Med. 108, 467–478.
Bunch, C. (1987),Chronic Lymphocytic Leukemia: Recent Progress and Future Direction (Gale, R. P. and Rai, K. R., eds.), Alan R. Liss, New York, pp. 373–381.
Kyle, R. A. (1975),Mayo Clin. Proc. 50, 29–40.
Twomey, J. J. (1973),Arch. Intern. Med. 132, 562–565.
Shaikh, B. K. S., Lombard, R. M., Appelbaum, P. C., and Bentz, M. S. (1982),Oncology 39, 78–82.
Fahey, J. L., Scoggins, R., Utz, J. P., and Szwed, C. F. (1963),Am. J. Med. 35, 698–707.
Perri, R. T., Hebbel, R. K. P., and Oken, M. M. (1981),Am. J. Med. 71, 935–940.
Espersen, F., Birgens, H. S., Hertz, J. B., and Drivsholm, A. (1984),Scand. J. Infect. Dis. 16, 169–173.
Doughney, K. B., Williams, D. M., and Penn, R. L. (1988),South. Med. J. 81, 855–858.
Savage, D. G., Lindenbaum, J., and Garrett, T. J. (1982),Ann. Intern. Med. 96, 47–50.
Fink, P. C. and Galanos, C. (1985),Immunobiology 169, 1–10.
Stiehm, E. R., Ashida, E., Kim, K. S., Winston, D. J., Haas, A., and Gale, R. P. (1987),Ann. Intern. Med. 107, 367–382.
Roifman, C. M., Lederman, H. M., and Gelfand, E. W. (1985),Intravenous Immunoglobulins. Royal Society of Medicine International Congress and Symposium Series, no. 84 (Waters, A. H. and Webster, A. D. B., eds.), Royal Society of Medicine, London, pp. 41–46.
Webster, A. D. B. and Lever, A. M. L. (1986),Clinical Use of Intravenous Immunoglobulins (Morell, A. and Nydegger, U. E., eds.), Academic Press, London, pp. 67–75.
Yap, P. L., Lightwood, J., and McClelland, D. B. L. (1985),Intravenous Immunoglobulins. Royal Society of Medicine International Congress and Symposium Series, no. 84 (Waters, A. H. and Webster, A. D. B., eds.), Royal Society of Medicine, London, pp. 31–39.
Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia (1988),N. Engl. J. Med. 319, 902–907.
Besa, E. C. (1984),Am. J. Med. 76 (3A), 209–218.
Ritch, P. S. and Anderson, T. (1987),Cancer 60, 2637–2640.
Besa, E. C. (1988),Am. J. Med. 84, 691–698.
Bussel, J. (1986),Vox Sang. 51 (suppl. 2), 69–73.
Clauvel, J. P., Vainchenker, W., Herrera, A., Dellagi, K., Vinci, G., Tabilio, A., and Lacombe, C. (1983),Br. J. Hematol. 55, 380–382.
McGuire, W. A., Yang, H. H., Bruno, E., Brandt, J., Briddell, R., Coates, T. D., and Hoffman, R. (1987),N. Engl. J. Med. 317, 1004–1008.
Salmon, S. E., Samal, B. A., Hayes, D. M., Hosley, H., Miller, S. P., and Schilling, A. (1967),N. Engl. J. Med. 277, 1336–1340.
Gordon, D. S., Hearn, E. B., Spira, T. J., Reimer, C. B., Phillips, D. J., and Schable, C. (1984),Am. J. Med. 76 (3A), 111–116.
Schedel, I. (1986),Clinical Use of Intravenous Immunoglobulins (Morell, A. and Nydegger, U. E., eds.), Academic Press, London, pp. 123–132.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Winkelstein, A., Jordan, P.S. Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma. Clinical Reviews in Allergy 10, 39–58 (1992). https://doi.org/10.1007/BF02914369
Issue Date:
DOI: https://doi.org/10.1007/BF02914369